Quest PharmaTech, Inc.
🇨🇦Canada
- Country
- 🇨🇦Canada
- Ownership
- Public
- Established
- 1996-01-01
- Employees
- 1
- Market Cap
- -
Clinical Trials
2
Active:1
Completed:1
Trial Phases
2 Phases
Phase 1:1
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (50.0%)Phase 2
1 (50.0%)A Controlled Study of the Effectiveness of Oregovomab (Antibody) Plus Chemotherapy in Advanced Ovarian Cancer
Phase 2
Completed
- Conditions
- Ovarian Neoplasms
- Interventions
- First Posted Date
- 2012-06-11
- Last Posted Date
- 2020-09-14
- Lead Sponsor
- Quest PharmaTech Inc.
- Target Recruit Count
- 97
- Registration Number
- NCT01616303
- Locations
- 🇺🇸
University of Connecticut Health Center, Farmington, Connecticut, United States
🇺🇸Northern Indiana Cancer Research Consortium, South Bend, Indiana, United States
News
No news found